0.9065 USD
-0.03 (-3.17%)
0.91 USD
+0 (+0.39%)
Taking everything into account, DCGO scores 3 out of 10 in our fundamental rating. DCGO was compared to 101 industry peers in the Health Care Providers & Services industry. DCGO has a great financial health rating, but its profitability evaluates not so good. DCGO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DCGO had negative earnings in the past year.
DCGO had a positive operating cash flow in the past year.
DCGO had positive earnings in 4 of the past 5 years.
In multiple years DCGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
DCGO has a Return On Assets of -14.58%. This is in the lower half of the industry: DCGO underperforms 77.23% of its industry peers.
The Return On Equity of DCGO (-19.07%) is worse than 64.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCGO's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of DCGO has declined.
DCGO's Gross Margin of 31.21% is fine compared to the rest of the industry. DCGO outperforms 60.40% of its industry peers.
In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DCGO has less shares outstanding than it did 1 year ago.
The debt/assets ratio for DCGO is higher compared to a year ago.
2.2 Solvency
DCGO has an Altman-Z score of 1.28. This is a bad value and indicates that DCGO is not financially healthy and even has some risk of bankruptcy.
DCGO has a Altman-Z score of 1.28. This is in the lower half of the industry: DCGO underperforms 68.32% of its industry peers.
The Debt to FCF ratio of DCGO is 0.32, which is an excellent value as it means it would take DCGO, only 0.32 years of fcf income to pay off all of its debts.
DCGO has a better Debt to FCF ratio (0.32) than 93.07% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that DCGO is not too dependend on debt financing.
The Debt to Equity ratio of DCGO (0.04) is better than 81.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Altman-Z | 1.28 |
ROIC/WACCN/A
WACC8.65%
2.3 Liquidity
A Current Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.59, DCGO belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
A Quick Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
DCGO has a better Quick ratio (2.59) than 82.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
The earnings per share for DCGO have decreased strongly by -194.14% in the last year.
Measured over the past years, DCGO shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.93% on average per year.
DCGO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.03%.
DCGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.60% yearly.
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
3.2 Future
The Earnings Per Share is expected to decrease by -42.21% on average over the next years. This is quite bad
The Revenue is expected to decrease by -20.20% on average over the next years. This is quite bad
EPS Next Y-311.85%
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue Next Year-49.22%
Revenue Next 2Y-31.84%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DCGO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
DCGO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DCGO is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.71 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as DCGO's earnings are expected to decrease with -42.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.9065
-0.03 (-3.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners50.6%
Inst Owner Change0%
Ins Owners9.01%
Ins Owner Change14.71%
Market Cap88.66M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.46
Price Target2.81 (209.98%)
Short Float %5.46%
Short Ratio2.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)0%
PT rev (3m)-10.57%
EPS NQ rev (1m)-10.98%
EPS NQ rev (3m)-21.34%
EPS NY rev (1m)-13.68%
EPS NY rev (3m)-21.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.24 | ||
| P/FCF | 1.71 | ||
| P/OCF | 1.53 | ||
| P/B | 0.33 | ||
| P/tB | 0.42 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)0.53
FCFY58.46%
OCF(TTM)0.59
OCFY65.2%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% | ||
| FCFM | 14.08% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.73% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 1.28 |
F-Score4
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-311.85%
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.22%
Revenue Next 2Y-31.84%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-161.23%
EBIT Next 3Y-28.18%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A
DOCGO INC / DCGO FAQ
What is the fundamental rating for DCGO stock?
ChartMill assigns a fundamental rating of 3 / 10 to DCGO.
What is the valuation status of DOCGO INC (DCGO) stock?
ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.
How profitable is DOCGO INC (DCGO) stock?
DOCGO INC (DCGO) has a profitability rating of 2 / 10.
What is the financial health of DOCGO INC (DCGO) stock?
The financial health rating of DOCGO INC (DCGO) is 7 / 10.